Cargando…
5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma
Approximately 85% colorectal cancers (CRCs) are thought to evolve through the adenoma‐to‐carcinoma sequence associated with specific molecular alterations, including the 5‐hydroxymethylcytosine (5hmC) signature in circulating cell‐free DNA (cfDNA). To explore colorectal disease progression and evalu...
Autores principales: | Xiao, ZeWen, Wu, Wendy, Wu, Chunlong, Li, Man, Sun, Fuming, Zheng, Lu, Liu, Gaojing, Li, Xiaoling, Yun, Zhiyuan, Tang, Jiebing, Yu, Yang, Luo, Shengnan, Sun, Wenji, Feng, Xiaohong, Cheng, Qian, Tao, Xue, Wu, Shuangxiu, Tao, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782095/ https://www.ncbi.nlm.nih.gov/pubmed/33107199 http://dx.doi.org/10.1002/1878-0261.12833 |
Ejemplares similares
-
5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma
por: Barazeghi, Elham, et al.
Publicado: (2016) -
5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma
por: Zhang, Chunyu, et al.
Publicado: (2022) -
Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas
por: Xu, Yiwen, et al.
Publicado: (2020) -
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
por: Wu, Tao, et al.
Publicado: (2020) -
Genomic mapping of 5-hydroxymethylcytosine in the human brain
por: Jin, Seung-Gi, et al.
Publicado: (2011)